Skip to content

Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect

Clinical Randomized Controlled Study on the Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04926896
Enrollment
336
Registered
2021-06-15
Start date
2020-09-20
Completion date
2024-12-21
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Control Group

Brief summary

In this research, a new bone harvesting technique is introduced in order to find an iliac crest bone harvesting method for patients with less trauma, less postoperative pain in donor sites, and lower incidence of postoperative complications, so as to get ideal bone grafting materials at a small cost, enhance the effect of osteogenesis repair on bone defect or fusion site, and improve the operation quality.

Detailed description

Based on the domestic and foreign research on minimally invasive bone harvesting, we have developed a disposable battery-powered bone harvesting device that can be used for milling bone tissues. Using this disposable battery-powered bone harvesting device, cancellous bone milling can be performed in a small bone hole with a diameter of 7.5 mm. The morselized bone or bone chips it milled can be used for bone fusion at the desired site. The technique adopts patented milling tool bit and electric drive, with high operation efficiency, so the surgery can be completed very quickly. The bone trauma in the operation can be significantly reduced and the pain in the donor site can be greatly alleviating. Moreover, the technique can obviously reduce the duration of bone harvesting and the cost of operating room. In addition, significant reductions in postoperative pain will also be helpful to a range of clinical advantages and benefits, such as the average hospitalization days, and will be expected to benefit significantly in patients undergoing autologous bone harvesting.

Interventions

PROCEDURETraditional iliac crest bone harvesting surgery

The experimental group and the control group do not have special requirements; perform the surgery according to the normal operation methods of different sites.

PROCEDUREMinimally invasive bone harvesting surgery

Minimally invasive bone harvesting surgery

Sponsors

West China Hospital
CollaboratorOTHER
Werner Wicker Klinik
CollaboratorNETWORK
Tongji Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Experimental group: Minimally invasive bone harvesting surgery group. Control group: Traditional iliac crest bone harvesting surgery group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with clinical bone defects or need for bone fusion; 2. Age 18 to 65, and gender is not limited; 3. Informed consent has been signed.

Exclusion criteria

1. Age less than 18 or greater than 65; 2. Patients with severe deformities of the iliac bone or extensive defects of the iliac bone, which are not suitable for bone extraction; 3. Patients with coagulation dysfunction; 4. Patients who are unwilling to perform iliac bone extraction; 5. BMI & lt; = 18.5 kg/m2; 6. Patients with type I and type II diabetes; 7. Osteoporosis(T & lt; = -2.5); 8. Moderate and severe anemia(hemoglobin & lt; 9g/L) or hypoproteinemia(albumin & lt; 30g/L); 9. Patients with malignant neoplasms; Patients with mental illness and those who are unconscious and unable to express themselves accurately.

Design outcomes

Primary

MeasureTime frameDescription
the comprehensive curative effect6 months after the operationthe healing rate of the bone graft site
the VAS score of pain in the donor site24 hours after the operationthe VAS score of pain in the donor site

Countries

China

Contacts

Primary ContactLi L Wanli, M.D.
liwanli@furunmed.com13967116021
Backup ContactLi L Hongmei
lihongmei@furunmed.com13857139616

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026